The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Comprehensive Research Report on Gene Q2U1U6 (AO090138000091) from Aspergillus oryzae

⚠️ Important Notice on Literature Availability

After comprehensive literature searches using the UniProt accession Q2U1U6, ORF name AO090138000091, and related search terms for Aspergillus oryzae chondroitin lyases, no direct experimental characterization of this specific protein was identified in the scientific literature. Therefore, the functional annotation provided below is based on bioinformatic inference from domain analysis, comparative genomics, and characterization of related enzymes from other organisms. This limitation must be acknowledged when interpreting the following report.

Protein Identification and Context

The protein Q2U1U6 (ORF name: AO090138000091) is annotated in UniProt as "DNA, SC138" from Aspergillus oryzae strain ATCC 42149 / RIB 40, commonly known as yellow koji mold. A. oryzae is an industrially important filamentous fungus widely used in food fermentation (sake, miso, soy sauce) and enzyme production (kjærbølling2020acomparativegenomics pages 1-2). Comparative genomics studies have revealed that species in Aspergillus section Flavi, including A. oryzae, encode abundant carbohydrate-active enzymes (CAZymes), averaging approximately 598 CAZymes per species, including numerous polysaccharide lyases involved in complex polysaccharide degradation (kjærbølling2020acomparativegenomics pages 1-2).

Domain Architecture and Predicted Function

The key structural feature of Q2U1U6 is the presence of a Chondroitin_lyas domain (InterPro IPR008929). This domain is characteristic of glycosaminoglycan-degrading polysaccharide lyases. Based on domain architecture and comparison to characterized enzymes, Q2U1U6 is predicted to function as a polysaccharide lyase with glycosaminoglycan (GAG)-degrading activity, likely belonging to the polysaccharide lyase family 8 (PL8), which encompasses many well-characterized chondroitin sulfate and dermatan sulfate lyases (rawat2022hungatellahathewayian pages 1-2, wang2020researchandapplication pages 4-5).

Predicted Enzymatic Mechanism

Polysaccharide lyases containing the Chondroitin_lyas domain cleave glycosidic bonds through a β-elimination mechanism, which is fundamentally different from the hydrolytic mechanism employed by glycoside hydrolases. The catalytic mechanism involves accepting a proton from the C5 position of the hexuronic acid residue while simultaneously donating a proton to the O4 position, resulting in β-elimination of the glycosidic bond (jiang2024acomprehensivereview pages 1-3). This mechanism generates products with a characteristic Δ4,5-unsaturated bond between C4 and C5 of the uronic acid residue at the non-reducing end, which can be detected by characteristic UV absorption at 232 nm (wang2020researchandapplication pages 4-5).

The reaction can be represented as cleavage of the β-1,4-glycosidic linkage between hexosamine (N-acetylgalactosamine in chondroitin/dermatan) and hexuronic acid (glucuronic acid or iduronic acid) residues in GAG chains (rawat2022hungatellahathewayian pages 1-2, wang2020researchandapplication pages 4-5).

Substrate Specificity

Based on the Chondroitin_lyas domain, Q2U1U6 is predicted to act on glycosaminoglycans (GAGs), particularly:

1. Chondroitin sulfate (CS): A sulfated GAG composed of repeating disaccharide units of D-glucuronic acid (GlcA) and N-acetylgalactosamine (GalNAc) with various sulfation patterns at C-4 and/or C-6 of GalNAc and C-2 of GlcA (wang2020researchandapplication pages 1-2, wang2020researchandapplication pages 2-4).

2. Dermatan sulfate (DS): Also called chondroitin sulfate B, which contains L-iduronic acid (IdoA) instead of glucuronic acid. DS is the stereoisomer of chondroitin where GlcA residues are epimerized to IdoA (wang2020researchandapplication pages 1-2, wang2020researchandapplication pages 2-4).

3. Hyaluronic acid (HA): A non-sulfated GAG composed of repeating disaccharides of GlcA and N-acetylglucosamine (GlcNAc), structurally similar to the chondroitin backbone (jiang2024acomprehensivereview pages 1-3, wang2020researchandapplication pages 4-5).

Different chondroitin lyases exhibit varying substrate specificities. Chondroitin ABC lyases can degrade CS, DS, and HA irrespective of sulfation or epimerization patterns, while chondroitin AC lyases are sensitive to C-5 epimerization and act only on CS and HA but not DS (wang2020researchandapplication pages 4-5). Without experimental characterization, the exact substrate range of Q2U1U6 cannot be definitively determined.

Predicted Reaction Products and Cleavage Pattern

The predicted products of Q2U1U6 activity are unsaturated oligosaccharides or disaccharides containing Δ4,5-unsaturated uronic acid residues (designated as ΔHexA in nomenclature). Polysaccharide lyases can operate through two distinct modes (rawat2022hungatellahathewayian pages 1-2, wang2020researchandapplication pages 4-5):

• Endolytic lyases: Cleave GAG chains internally at random positions, initially producing larger oligosaccharides that are progressively degraded to smaller fragments and eventually disaccharides.

• Exolytic lyases: Successively release unsaturated disaccharides from either the reducing or non-reducing end of GAG chains without producing larger oligosaccharide intermediates.

For example, the well-characterized chondroitin ABC lyase from Proteus vulgaris exists as a mixture of endolytic (CSase ABC I) and exolytic (CSase ABC II) enzymes (wang2020researchandapplication pages 4-5). A recently characterized chondroitin ABC lyase from Hungatella hathewayi was shown to cleave GAGs predominantly in an exo-mode to produce unsaturated disaccharides as the primary product (rawat2022hungatellahathewayian pages 1-2). The specific cleavage mode of Q2U1U6 remains unknown without experimental validation.

Predicted Cellular Localization

Fungal CAZymes, particularly those involved in polysaccharide degradation, are commonly secreted into the extracellular environment to enable degradation of complex polymers that cannot cross the cell membrane (kjærbølling2020acomparativegenomics pages 1-2). Aspergillus species, including A. oryzae, are renowned for their ability to secrete large quantities of diverse enzymes, making them important industrial enzyme producers (kjærbølling2020acomparativegenomics pages 1-2).

In bacteria, many characterized chondroitin lyases have been found to contain secretory signal peptides. For instance, in the gut bacterium Hungatella hathewayi, the majority of PL8 family proteins (43 out of 48) possessed secretory signal peptides, and chondroitin lyase activity was found predominantly in the culture supernatant rather than cell-associated (rawat2022hungatellahathewayian pages 1-2, rawat2022hungatellahathewayian pages 2-5). By analogy, Q2U1U6 from A. oryzae is likely to be secreted, though signal peptide prediction and experimental localization studies would be needed for confirmation.

Biological Processes and Pathway Context

Polysaccharide lyases with chondroitin-degrading activity are involved in carbohydrate catabolism pathways, specifically the degradation of glycosaminoglycans. In the fungal ecological context, such enzymes may contribute to environmental polymer degradation rather than canonical intracellular metabolism (rawat2022hungatellahathewayian pages 1-2, kjærbølling2020acomparativegenomics pages 1-2).

In bacterial systems, GAG degradation involves multiple coordinated steps with various proteins including polysaccharide lyases for initial depolymerization, glycoside hydrolase 88 (GH88) for further processing of unsaturated disaccharides, sulfatases for desulfation, and transporters for substrate uptake (rawat2022hungatellahathewayian pages 1-2, rawat2022hungatellahathewayian pages 2-5). However, the complete GAG utilization pathway in fungi has not been extensively characterized, and it remains unclear whether A. oryzae possesses a complete enzymatic machinery for GAG catabolism similar to that found in bacteria.

The industrial relevance of A. oryzae is primarily in the production of enzymes for plant biomass degradation (cellulases, hemicellulases, pectinases) and food fermentation (kjærbølling2020acomparativegenomics pages 1-2). The presence of a putative chondroitin lyase is intriguing but its specific role in the biology or industrial applications of A. oryzae has not been investigated.

Gaps in Knowledge and Research Needs

The following critical aspects of Q2U1U6 function remain uncharacterized:

1. Experimental validation: No biochemical characterization, enzymatic assays, or gene expression studies have been published for this specific protein.

2. Substrate specificity: The precise substrate range (CS vs. DS vs. HA), sulfation pattern preferences, and catalytic efficiency are unknown.

3. Cleavage mode: Whether the enzyme functions as an endolyase or exolyase has not been determined.

4. Expression conditions: Under what growth conditions or in response to which substrates the gene is expressed remains unknown.

5. Physiological role: The biological function of a putative GAG-degrading enzyme in a saprophytic fungus primarily known for plant biomass degradation is unclear.

6. Structure: No structural information is available to confirm the predicted mechanism or identify active site residues.

Summary Table

Table: This table summarizes what can be stated about Aspergillus oryzae Q2U1U6 with confidence after verifying that direct literature is lacking. It distinguishes domain-based functional inference from experimentally demonstrated facts.

Conclusions

The protein Q2U1U6 (AO090138000091) from Aspergillus oryzae RIB 40 contains a Chondroitin_lyas domain and is predicted to function as a polysaccharide lyase capable of degrading glycosaminoglycans through a β-elimination mechanism. Based on domain analysis and comparison to characterized enzymes from other organisms, the most likely substrates are chondroitin sulfate, dermatan sulfate, and possibly hyaluronic acid, with predicted products being unsaturated oligosaccharides or disaccharides (wang2020researchandapplication pages 1-2, rawat2022hungatellahathewayian pages 1-2, jiang2024acomprehensivereview pages 1-3, wang2020researchandapplication pages 4-5). The enzyme is likely secreted, consistent with the general biology of fungal CAZymes and Aspergillus secretomes (kjærbølling2020acomparativegenomics pages 1-2).

However, it is crucial to emphasize that these functional predictions are based entirely on bioinformatic inference and have not been validated experimentally. Direct biochemical characterization, including substrate specificity assays, product analysis, determination of cleavage mode, and localization studies, would be required to confirm the predicted function and elucidate the precise role of this protein in A. oryzae biology.

The lack of published research on this specific gene highlights it as a potential target for future functional genomics studies, particularly given the growing interest in microbial glycosaminoglycan-degrading enzymes for biotechnological and therapeutic applications (wang2020researchandapplication pages 1-2, rawat2022hungatellahathewayian pages 1-2, jiang2024acomprehensivereview pages 1-3).

References

1. (kjærbølling2020acomparativegenomics pages 1-2): Inge Kjærbølling, Tammi Vesth, Jens C. Frisvad, Jane L. Nybo, Sebastian Theobald, Sara Kildgaard, Thomas Isbrandt Petersen, Alan Kuo, Atsushi Sato, Ellen K. Lyhne, Martin E. Kogle, Ad Wiebenga, Roland S. Kun, Ronnie J. M. Lubbers, Miia R. Mäkelä, Kerrie Barry, Mansi Chovatia, Alicia Clum, Chris Daum, Sajeet Haridas, Guifen He, Kurt LaButti, Anna Lipzen, Stephen Mondo, Jasmyn Pangilinan, Robert Riley, Asaf Salamov, Blake A. Simmons, Jon K. Magnuson, Bernard Henrissat, Uffe H. Mortensen, Thomas O. Larsen, Ronald P. de Vries, Igor V. Grigoriev, Masayuki Machida, Scott E. Baker, and Mikael R. Andersen. A comparative genomics study of 23 aspergillus species from section flavi. Nature Communications, Feb 2020. URL: https://doi.org/10.1038/s41467-019-14051-y, doi:10.1038/s41467-019-14051-y. This article has 219 citations and is from a highest quality peer-reviewed journal.

2. (rawat2022hungatellahathewayian pages 1-2): Parkash Singh Rawat, Yan Li, Weixin Zhang, Xiangfeng Meng, and Weifeng Liu. Hungatella hathewayi, an efficient glycosaminoglycan-degrading firmicutes from human gut and its chondroitin abc exolyase with high activity and broad substrate specificity. Nov 2022. URL: https://doi.org/10.1128/aem.01546-22, doi:10.1128/aem.01546-22. This article has 31 citations and is from a peer-reviewed journal.

3. (wang2020researchandapplication pages 4-5): Wenshuang Wang, Liran Shi, Yong Qin, and Fuchuan Li. Research and application of chondroitin sulfate/dermatan sulfate-degrading enzymes. Frontiers in Cell and Developmental Biology, Dec 2020. URL: https://doi.org/10.3389/fcell.2020.560442, doi:10.3389/fcell.2020.560442. This article has 47 citations.

4. (jiang2024acomprehensivereview pages 1-3): Jia-Yu Jiang, Dai Xue, Jin-Song Gong, Qin-Xin Zheng, Yue-Sheng Zhang, Chang Su, Zheng-Hong Xu, and Jin-Song Shi. A comprehensive review on microbial hyaluronan-degrading enzymes: from virulence factors to biotechnological tools. Bioresources and Bioprocessing, Dec 2024. URL: https://doi.org/10.1186/s40643-024-00832-x, doi:10.1186/s40643-024-00832-x. This article has 12 citations and is from a peer-reviewed journal.

5. (wang2020researchandapplication pages 1-2): Wenshuang Wang, Liran Shi, Yong Qin, and Fuchuan Li. Research and application of chondroitin sulfate/dermatan sulfate-degrading enzymes. Frontiers in Cell and Developmental Biology, Dec 2020. URL: https://doi.org/10.3389/fcell.2020.560442, doi:10.3389/fcell.2020.560442. This article has 47 citations.

6. (wang2020researchandapplication pages 2-4): Wenshuang Wang, Liran Shi, Yong Qin, and Fuchuan Li. Research and application of chondroitin sulfate/dermatan sulfate-degrading enzymes. Frontiers in Cell and Developmental Biology, Dec 2020. URL: https://doi.org/10.3389/fcell.2020.560442, doi:10.3389/fcell.2020.560442. This article has 47 citations.

7. (rawat2022hungatellahathewayian pages 2-5): Parkash Singh Rawat, Yan Li, Weixin Zhang, Xiangfeng Meng, and Weifeng Liu. Hungatella hathewayi, an efficient glycosaminoglycan-degrading firmicutes from human gut and its chondroitin abc exolyase with high activity and broad substrate specificity. Nov 2022. URL: https://doi.org/10.1128/aem.01546-22, doi:10.1128/aem.01546-22. This article has 31 citations and is from a peer-reviewed journal.

Artifacts

• Edison artifact artifact-00

Citations

1. jiang2024acomprehensivereview pages 1-3
2. wang2020researchandapplication pages 4-5
3. rawat2022hungatellahathewayian pages 1-2
4. wang2020researchandapplication pages 1-2
5. wang2020researchandapplication pages 2-4
6. rawat2022hungatellahathewayian pages 2-5
7. https://doi.org/10.1038/s41467-019-14051-y,
8. https://doi.org/10.1128/aem.01546-22,
9. https://doi.org/10.3389/fcell.2020.560442,
10. https://doi.org/10.1186/s40643-024-00832-x,

AIGR Deep Research Report — Q2U1U6 (ASPOR): Glycoside Hydrolase vs Polysaccharide Lyase

Gene: Q2U1U6 (Q2U1U6_ASPOR), Aspergillus oryzae RIB40, ORF AO090138000091 · 134 aa · PE=4 (Predicted)
Hypothesis under test (computational_prediction): ProtNLM2 predicts GO:0004553 "hydrolase activity, hydrolyzing O-glycosyl compounds" (i.e. glycoside hydrolase, GH) for Q2U1U6, whose only signature is IPR008929 / SUPFAM SSF48230 (Chondroitin AC/alginate lyase fold). Is Q2U1U6 a GH (hydrolysis) or a polysaccharide lyase (PL, β-elimination), and is the prediction supported or a class misassignment?

Executive Judgment

Verdict: REFUTED (class misassignment), with the residual signal being at most a weak, fold-level, non-catalytic resemblance.

The ProtNLM2 GO:0004553 (O-glycosyl hydrolase) prediction is not supported and is best read as a CAZy class misassignment:

1. Wrong mechanistic class. The single piece of evidence behind any enzymatic call is a fold-level match to SSF48230 / IPR008929, the (α/α)-toroid scaffold of CAZy polysaccharide lyases (PL5/PL8/PL15/PL35/PL40). These enzymes cleave glycosidic bonds by β-elimination (a lyase, EC 4.2.2.-), producing Δ4,5-unsaturated uronate — mechanistically distinct from hydrolysis (EC 3.2.1.-, GO:0004553). If any activity were implied by the fold, it would be lyase, not hydrolase. Predicting a hydrolase from a lyase fold is a category error.
2. Too small and only a partial match. Q2U1U6 is 134 aa; the SSF48230 match covers only residues 6–97 (92 aa) with a weak SUPFAM E-value (4.03e-06). Quantitatively decisive: all 53 reviewed IPR008929 members are 331–1372 aa (median 682); 0% are shorter than 134 aa, and the smallest members are annotated alginate/polysaccharide lyases. Q2U1U6 is ~2.5× smaller than the smallest family member and ~5× below the median — it cannot reconstitute the (α/α)₆ toroid, its substrate groove, or the His/Tyr(/Arg/Asn) catalytic constellation, nor does it provide the Asp/Glu acid–base pair of a hydrolase (geometry check found no canonical GH di-carboxylate pair; only a weak, incomplete His124–Tyr17–Asn85 cluster).
3. No positive evidence for catalysis of any kind. UniProt has no EC and no GO for this entry; PE=4 (Predicted); name is a placeholder ("DNA, SC138"). No primary literature characterizes this ORF. The AlphaFold model is confidently folded (global pLDDT 92.3) but is a compact all-α domain (~58% helix, no β-sheet, Rg 15.1 Å) — consistent with a fragment of the toroid superfamily, not a functional enzyme.

Most important caveat: "Refuted" applies specifically to the GH / GO:0004553 claim. The data do not license a positive PL annotation either; the honest state is uncharacterized protein with a weak all-α fold resemblance to the chondroitin/alginate lyase superfamily. This should not be annotated with any molecular-function enzyme term without experimental evidence.

Evidence Matrix

GO Curation Implications (leads requiring curator verification)

• GO:0004553 (MF, hydrolase / O-glycosyl): Do NOT add. Not supported; a mechanistic class misassignment (lyase fold → hydrolase term). If it appears in any prior action, recommend removal / rejection of the ProtNLM-derived prediction.
• Do NOT substitute a PL/lyase MF term either (e.g., GO:0016837 carbon-oxygen lyase, or GO:0030246-type). The evidence is fold-level and partial only; there is no experimental or full-domain basis for a positive enzyme annotation.
• Recommended stance: leave molecular function uncharacterized (no enzyme MF term). At most, an internal note that the protein shows a weak, partial structural resemblance to the chondroitin/alginate lyase (α/α-toroid) superfamily — orientation only, not an annotation.
• Avoid "protein binding" as a fallback; it is uninformative and equally unsupported.

Mechanistic Scope

The term tested is a direct molecular-function claim (catalysis of O-glycosidic bond hydrolysis). The analysis addresses that directly: (a) the fold family is catalytically a lyase, not a hydrolase; (b) the protein lacks the size and complete active-site architecture for either mechanism. No downstream phenotype, pathway, or developmental inference is involved — this is purely a molecular-activity assignment, and it fails at the molecular level.

Conflicts and Alternatives

• Paralog/label-propagation bias (now supported): A. oryzae has four IPR008929 paralogs — Q2TXR4 (406 aa), Q2USR3 (453 aa), Q2UB60 (395 aa) and Q2U1U6 (134 aa). Q2U1U6 is the lone truncated outlier; ProtNLM2 (a name/label language model) likely over-generalized a carbohydrate-active label from the larger paralogs, collapsing the mechanistically distinct PL vs GH distinction onto a fragment.
• No GH anywhere in the superfamily: Across all organisms, small (≤200 aa) IPR008929 members are annotated as alginate/mannuronate lyases, dermatan sulfate epimerase (EC 5.1.3.19), or uncharacterized — i.e. β-elimination/epimerase (carbanion) chemistry. None are glycoside hydrolases, confirming GO:0004553 is off-class for this fold.
• Alternative benign interpretation: Q2U1U6 may be a non-catalytic small all-α protein (structural/binding module) or a degenerate/truncated remnant of a lyase-fold ancestor. The confident AlphaFold fold plus small size is consistent with a stable mini-domain (or a truncated gene model) rather than a complete enzyme.
• Database carry-over risk: because the entry is TrEMBL/PE=4 with no GO, any downstream GH annotation would propagate an unverified, off-class prediction.

Knowledge Gaps

1. No biochemical assay for Q2U1U6 — checked: no primary literature on this ORF. Matters because activity (GH vs PL vs none) is undecidable from sequence alone. Resolve with recombinant expression + activity screen (see below).
2. No structural superposition to a characterized PL was run (no Foldseek/DALI available here). Checked fold class computationally (all-α, partial); a structural search against PDB PL/GH representatives would sharpen the "fragment vs domain" call.
3. Catalytic-residue geometry not confirmed in 3D: candidate His7/His51/His124 and multiple Tyr exist in sequence, but whether any form a lyase-like His/Tyr dyad in the model was not measured. Matters for judging even a lyase hypothesis.

Discriminating Tests

• Foldseek/DALI of AF-Q2U1U6-F1 against PDB: does it match a full toroid PL catalytic domain or only an isolated α-hairpin cluster? (Fast, decisive on the "partial fold" claim.)
• Active-site geometry check in the model: measure spatial proximity/orientation of His/Tyr candidates and any Asp/Glu pair; absence of a coherent catalytic center supports "non-catalytic."
• HMMER/CAZy dbCAN scan: does Q2U1U6 hit any PL or GH family HMM above threshold, or only the SUPFAM fold? Lack of a family-level PL/GH hit corroborates misassignment.
• Experimental (definitive): recombinant expression and (i) thiobarbituric-acid / A232 assay for β-eliminative unsaturated-product formation (lyase) vs (ii) reducing-sugar/pNP-glycoside assays (hydrolase), on chondroitin/alginate/ulvan and generic glycosides.

Curation Leads (verify before acting)

• Action: Reject/remove the ProtNLM2 GO:0004553 prediction as a PL→GH class misassignment; do not add any enzyme MF term.
• Candidate snippets to verify (exact quotes): PMID 34392362 — "cleaves the β-1,4 glycosidic linkage of chondroitin sulfate (CS) by β-elimination"; PMID 20507980 — "degraded by alginate lyases through a beta-elimination reaction" and "His(311) and Tyr(365) as the catalytic base and acid."
• Suggested reviewer question: Should the entry carry a fold-level "chondroitin/alginate lyase-like superfamily" note (orientation only) while remaining unannotated for MF?
• Suggested experiment: heterologous expression + paired lyase (A232/TBA) and hydrolase (reducing-sugar/pNP) assays to establish whether Q2U1U6 has any glycan-cleaving activity at all.

Provenance

Analyses executed (code + outputs retained in the iteration log):
- Iteration 1: UniProt text fetch (134 aa, no GO/EC, PE=4); InterPro API (SSF48230 match res 6–97, E=4.03e-06); AlphaFold API + PDB parse (global pLDDT 92.3; region 6–97 pLDDT 94.3; ~58% helix; no β-sheet; Rg 15.1 Å; catalytic-candidate residue inventory).
- Iteration 2: IPR008929 reviewed-member length distribution (n=53: 331–1372 aa, median 682, 0% < 134 aa; smallest members = alginate/PL lyases); AlphaFold active-site geometry test (no canonical GH di-carboxylate acid/base pair; single His124–Tyr17 5.3 Å dyad + Asn85, incomplete lyase-type cluster).
- Iteration 3: UniProt paralog query (4 A. oryzae IPR008929 proteins: 406/453/395/134 aa — Q2U1U6 is the truncated outlier); UniProt query of ≤200-aa IPR008929 members across all organisms (annotated as alginate/mannuronate lyases, dermatan sulfate epimerase, or uncharacterized — no glycoside hydrolases).
- Literature via PubMed (PMIDs 20507980, 34392362, 41532755, 22297996, 18500999).

Artifacts

• OpenScientist final report
• OpenScientist final report